Details of the Drug

General Information of Drug (ID: DMUSOM9)

Drug Name

ABBV-CX-2029

Indication

Disease Entry	ICD 11	Status	REF
Hematologic tumour	2B33.Y	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Antibody drug conjugate

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Transferrin receptor protein 1 (TFRC)	TT8MG4S	TFR1_HUMAN	Not Available	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	Clinical pipeline report, company report or official report of AbbVie.